Have you missed your cancer screenings?

May 22, 2020
 

Mays Cancer Center experts to discuss why getting screenings now is important during May 29 webinar  SAN ANTONIO (May 22, 2020) — Studies have shown that individuals with cancer who get COVID-19 are more likely to have poor outcomes. And with everyone staying home during the pandemic, many people have missed their regular cancer screenings. […]



Close up of medical drip or IV drip chamber in patient room.

Second phase of clinical trial for promising COVID-19 drug begins

May 15, 2020
 

Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.



An image of the virus that causes COVID-19 emerging from a cell

UT Health San Antonio, University Hospital begin second phase of clinical trial for promising COVID-19 drug

May 13, 2020
 

Media contact: Rosanne Fohn, (210) 567-3026, fohn@uthscsa.edu SAN ANTONIO (May 11, 2020) — The COVID-19 Infectious Disease team at UT Health San Antonio and University Health System is beginning the second stage of the remdesivir clinical trial, which is being sponsored by the National Institute of Allergy and Infectious Diseases, NIAID. This second phase of […]



Emergency Health Sciences student killed in car crash

May 13, 2020
 

Asante Sebastian Contreras, age 20, and a student in the Department of Emergency Health Sciences Paramedic Certification Program at UT Health San Antonio, died in a traffic crash on Sunday, May 3, in San Antonio. Contreras worked as an emergency medical technician for an ambulance service in San Antonio and, as a student in the […]


Close up of medical drip or IV drip chamber in patient room.

FDA gives emergency authorization to COVID-19 drug

May 4, 2020
 

Remdesivir is the first anti-viral drug that has been shown to benefit patients with COVID-19 in a randomized clinical trial.



COVID-19 Coronavirus Infections Viruses

FDA gives emergency authorization to COVID-19 drug being tested by UT Health San Antonio, University Hospital

May 2, 2020
 

SAN ANTONIO (May 1, 2020) — The FDA on May 1 gave emergency authorization to a new anti-viral drug to treat patients with COVID-19. The announcement was made during an afternoon news conference by President Trump. It comes two days after the National Institute of Allergy and Infectious Diseases (NIAID) released preliminary results of a […]